Anna Belloni Fortina
Overview
Explore the profile of Anna Belloni Fortina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cassalia F, Danese A, DAcunto C, Russo A, Zengarini C, Stanganelli I, et al.
Dermatol Reports
. 2025 Feb;
PMID: 39969069
Social media platforms have become integral to healthcare communication, particularly in dermatology, where visual assessment and patient education are paramount. While platforms like Instagram, Facebook, and Twitter offer significant opportunities...
2.
Barei F, Calzari P, Pezzolo E, Napolitano M, Rossi M, Guanti M, et al.
Clin Exp Dermatol
. 2025 Feb;
PMID: 39899459
Background: Tralokinumab has demonstrated efficacy in the treatment atopic dermatitis (AD) in both clinical trials and real-world settings. However, limited data exists on the long-term use of tralokinumab in real-world...
3.
Cassalia F, Lunardon A, Frattin G, Danese A, Caroppo F, Belloni Fortina A
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860587
Psoriasis is a chronic, immune-mediated skin disease significantly impacting women, with disease severity often modulated by hormonal fluctuations. This review examines the influence of hormonal changes on the course of...
4.
Rufer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink J, Bonadonna P, et al.
Leukemia
. 2025 Jan;
39(3):675-683.
PMID: 39815050
Expression of CD2, CD25 and/or CD30 in extracutaneous mast cells (MC) is a minor diagnostic criterion for systemic mastocytosis (SM) in the classification of the World Health Organization and International...
5.
Cassalia F, Danese A, Cocchi E, Vaienti S, Bolzon A, Franceschin L, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796784
Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade sarcoma that presents diagnostic challenges due to its resemblance to benign lesions [...].
6.
Tartaglia J, Franceschin L, Tudurachi I, Ciolfi C, Caroppo F, Belloni Fortina A
Clin Case Rep
. 2024 Dec;
12(12):e9209.
PMID: 39670074
While atypical, the development of psoriatic plaques over vascular malformations in children is plausible and should not necessarily prompt clinicians to perform costly or invasive procedures.
7.
Stingeni L, Fargnoli M, Guarneri F, Balato A, Corazza M, Belloni Fortina A, et al.
Dermatol Ther (Heidelb)
. 2024 Nov;
15(1):75-93.
PMID: 39607665
Introduction: Chronic hand eczema (CHE) is an inflammatory skin condition characterized by different pathomechanisms, clinical presentations, and prognoses. Treatment is often challenging because of limited approved drugs, and severe CHE...
8.
Denti F, Guerra E, Caroppo F, Abruzzese P, Alessi F, Barone F, et al.
Healthcare (Basel)
. 2024 Sep;
12(18).
PMID: 39337146
This study, employing an interim analysis, investigates the effects of the Dermamecum protocol, a structured educational and tailored approach that stratifies ostomy patients into risk paths (green, yellow, red) based...
9.
Cassalia F, Federico S, Danese A, Franceschin L, Amato S, Gratteri F, et al.
J Pers Med
. 2024 Aug;
14(8).
PMID: 39202063
Localized scleroderma (LS), commonly known as morphea, presents a significant clinical challenge due to its chronic, inflammatory nature affecting the skin and potentially underlying tissues. This systematic review explores the...
10.
Caroppo F, Cassalia F, Milan E, Belloni Fortina A
JAAD Case Rep
. 2024 Jul;
50:79-81.
PMID: 39070923
No abstract available.